Pharma firm Yunnan Baiyao sees synergy in merger with parent

Listed State-owned pharmaceutical firm Yunnan Baiyao Group Co Ltd said on Thursday that it was making steady progress on its planned merger with parent Yunnan Baiyao Holdings Co Ltd, and said the new combined entity will have greater synergy in its business operations.

"The merger will raise the brand's global competitiveness, upgrade its overall structure and help bring in more funds," said Wang Rong, vice-chairman of Yunnan Baiyao Holdings Co Ltd.

Currently Yunnan Baiyao Group has strengths in product manufacturing, marketing, research and development and human resources, while Yunnan Baiyao Holdings has ample financial resources. An amalgamation of the two firms will help upgrade the overall and financial capabilities, said industry insiders.